Dr. Howard Smith Oncall

Vidcast:  https://youtu.be/V4K0AKnztjM   Here are the quickie reports about cutting edge medical and healthcare discoveries this 1st week of June, 2022.   A new Swiss perfusion technique keeps donor livers alive and well for up to 3 days while they await transplantation into recipients.  In the past, the liver would only tolerate a 12 hour maximum residence outside the human body.  The additional time allows transportation for longer distances as well as the laboratory and tissue testing necessary to assume a good match and long-term function.   https://www.nature.com/articles/s41587-022-01354-7     From NY’s Rockefeller University comes the news that a new synthetic antibiotic called cilagicin capably neutralizes even the nastiest, drug resistant bacteria including MRSA and C. difficile.  The drug is based on a computer prediction regarding the type of molecule a bacterium would create to protect itself from its more aggressive cousins.  Cilagicin works effectively by combining 2 molecules that together irre